Acquired increases of human erythrocyte purine enzymes

Irving H. Fox(Takeda (United States)), Sheila Lacroix, Dale A. Dotten(Wellesley Institute), Pamela J. Marchant

Metabolism

May 1, 1976

10.1016/0026-0495(76)90011-1

Cited by 5

Related Papers

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

|New England Journal of Medicine|2013|2.9k

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

|New England Journal of Medicine|2013|2.7k

The safety of vedolizumab for ulcerative colitis and Crohn's disease

|Gut|2016|810

Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed

|Gastroenterology|2014|714

Treatment of Ulcerative Colitis with a Humanized Antibody to the α <sub>4</sub> β <sub>7</sub> Integrin

|New England Journal of Medicine|2005|694